AstraZeneca's 450 million vaccine plant at risk as government reconsiders financial backing
Briefly

from Business Matters6 months ago
AstraZeneca's proposed £450 million vaccine manufacturing facility is under scrutiny as the government considers significant cuts to its financial support, raising concerns about future investments.
Business Mattershttps://bmmagazine.co.uk/news/astrazenecas-450-million-vaccine-plant-at-risk-as-government-reconsiders-financial-backing/
While AstraZeneca's CEO expresses confidence in the UK life sciences sector, he highlights increasing concerns regarding the business climate and fiscal decisions under the new Chancellor.
Business Mattershttps://bmmagazine.co.uk/news/astrazenecas-450-million-vaccine-plant-at-risk-as-government-reconsiders-financial-backing/
Read at Business Matters
#astrazeneca #uk-government #vaccine-manufacturing #investment #life-sciences
[
|
]